Yorktown Management & Research Company »

Stoke Therapeutics shares owned by Yorktown Management & Research Company

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Yorktown Management & Research Company from 13F filings

Historical chart of Yorktown Management & Research Company investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Yorktown Management & Research Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Yorktown Management & Research Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $299k 9.2k 32.72

More positions owned by Yorktown Management & Research Company

Comfort Systems USA (FIX)
Ies Hldgs (IESC)
KLA Corporation Com New (KLAC)
iShares Convertible Bond ETF Conv Bd Etf (ICVT)
SPDR Bloomberg Convertible Securities ETF St Str Conv Etf (CWB)
Vanguard Emerging Markets Government Bond ETF Em Mk Gov Bd Etf (VWOB)
Guardant Health (GH)
Stonex Group (SNEX)
Fabrinet SHS (FN)
NOVA MEASURING Instruments L (NVMI)
ACM Research Com Cl A (ACMR)
Arista Networks Com Shs (ANET)
iShares iBoxx $ Investment Grade Corporate Bond Iboxx Inv Cp Etf (LQD)
WESCO International (WCC)
FTAI Aviation SHS (FTAI)

View all positions for Yorktown Management & Research Company

Top funds holding Stoke Therapeutics

BlackRock
Rtw Investments
FMR
Lynx1 Capital Management
Redmile Group
Wellington Management Company
Morgan Stanley
Baker Bros. Advisors
Toronto-Dominion Bank
Vanguard Capital Management
BVF
State Street Corporation
Siren
T. Rowe Price Associates
Deerfield Management Company

View all funds holding Stoke Therapeutics